Clinical Trials Directory

Trials / Completed

CompletedNCT03033602

Brief Treatment for Posttraumatic Stress Disorder

Brief Treatment for PTSD: Enhancing Retention and Engagement

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
169 (actual)
Sponsor
Boston VA Research Institute, Inc. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The primary goal of this study is to examine whether a brief treatment approach for PTSD is equally efficacious in the treatment of active duty service members relative to a first line treatment approach that requires much greater treatment dose.

Detailed description

The goal of this randomized clinical trial is to investigate if a brief, written intervention for posttraumatic stress disorder (PTSD), Written Exposure Therapy (WET), is non-inferior compared to an evidenced-based behavioral therapy, Cognitive Processing Therapy-Cognition only (CPT-C), in the treatment of PTSD in active duty military men and women with a diagnosis of PTSD who have deployed in support of a post-9/11. The primary study outcome is change in symptom severity as assessed by the Clinician Administered PTSD Scale for Diagnostic and Statistical Manual-5 edition (CAPS-5). Independent assessors evaluated participants using the CAPS-5 at baseline, 10-, 20-, and 30-week after the first treatment session.

Conditions

Interventions

TypeNameDescription
BEHAVIORALwritten exposure therapyfive sessions of writing about traumatic experience.
BEHAVIORALCPT, cognitive only12 sessions of cognitive therapy related to traumatic experience.

Timeline

Start date
2015-07-20
Primary completion
2020-12-15
Completion
2021-03-31
First posted
2017-01-27
Last updated
2023-05-24
Results posted
2023-05-24

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03033602. Inclusion in this directory is not an endorsement.